ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos

May 9, 1997

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001

Magnson Makes It Clear Senate Will Add Substantial Sums To Budget, Objects To Training Grant Phaseout

May 17, 1974